LEXINGTON, Ky. (Jan. 12, 2024) — The University of Kentucky will mark a decade o...
China has officially granted approval for the sale of Leqembi, a revolutionary A...
Researchers from Harvard University and the Broad Institute, led by Dr. David Li...
GSK has revealed a contract to acquire Aiolos Bio and its phase 2 asthma medicin...
3M Health Care has received a $34.2m award to improve the treatment of traumatic...
GSK has gained approval from the China National Medical Products Administration ...
Myrobalan Therapeutics has secured $24m in a Series A funding round to develop C...
Oratrope is a small molecule commercialized by Lumos Pharma, with a leading Phas...
Though not approved in the US, Laboratoires Delbert’s extencilline will be the a...
Mirati filed a marketing authorisation application to the EMA for Krazati for pa...
Innovent has reported positive Phase III results for mazdutide, Eli Lilly’s next...
Expanded patient groups at risk of progression to severe Covid-19 will be eligib...
BridgeBio submitted the NDA with US FDA for the TTR stabiliser in December 2023 ...
Evotec has announced a collaboration with the Crohn's & Colitis Foundation to ad...
The 100,000 Genomes Project is a major research endeavor to discover how our gen...
A new study found that 60% of the physicians who helped compile the APA’s offici...
